Ravelcare IPO Overview
Shark Tank-featured D2C beauty & personal care brand raising ₹24.10 cr via 100% fresh issue of 18.54L shares. Price: ₹123-130. Lot: 1,000 shares (₹2.60L min). Funds for marketing (₹11.5 cr), new Amravati plant (₹7.8 cr), corporate purposes.
Founded 2018, 7 years old. Custom haircare/skincare sold via website, Amazon, Flipkart, Myntra, Blinkit.
Products: shampoo, conditioner, serum, oil, face wash. Clean, customized, cruelty-free. FY25: ₹24.98 cr revenue (+12%), ₹5.25 cr PAT (+5%). H1 FY26: ₹14.4 cr revenue, ₹3.2 cr PAT. P/E: 12.4x.
Anchor: ₹6.83 cr raised.
Lead: Marwadi Chandarana. Analyst: “Fully priced, longer gestation”. Stagnant growth, crowded market, contract manufacturing dependency. Competes with Mamaearth, Honasa, Nykaa, Plum.
IPO DETAILED INFORMATION
Issue Details
| Parameter | Details |
| IPO Type | SME |
| IPO Open Date | 1 December 2025 (Sunday) |
| IPO Close Date | 3 December 2025 (Tuesday) |
| Anchor Investor Date | 28 November 2025 (Thursday) |
| Allotment Date | 4 December 2025 (Wednesday) – Expected |
| Credit to Demat | 5 December 2025 (Thursday) – Expected |
| Refund Initiation | TBD |
| Listing Date | 8 December 2025 (Monday) – Tentative |
| Price Band | ₹123 – ₹130 per share |
| Face Value | ₹10 per share |
| Lot Size | 1,000 shares |
| Min Investment (Retail) | ₹2,60,000 (2 lots / 2,000 shares at upper band) |
| sHNI Investment | ₹3,90,000 (3 lots / 3,000 shares) minimum |
| bHNI Investment | TBD |
| Issue Size | ₹24.10 crore total |
| Fresh Issue | ₹24.10 crore (100% fresh issue) – ₹22.88 cr net |
| Offer for Sale (OFS) | NIL |
| Total Shares Offered | 18,54,000 equity shares |
| Listing | BSE SME (Emerge Platform) |
| Post-Issue Market Cap | ~₹86 crore (at upper price band) |
| P/E Ratio | ~12.38x (FY25 basis, pre-issue) |
| EPS | ₹10.50 (FY25, pre-issue) |
| NAV | ₹55.56 per share (estimated post-issue) |
| Expected Listing Price | ₹142-146 (9-12% gains expected) |
| Anchor Investment | ₹6.83 crore raised from anchor investors on Nov 28 (5,25,000 shares – 28.32%) |
Issue Break-up
| Category | Allocation | Shares |
| QIB (Qualified Institutional Buyers) | 8,76,000 shares (ex-anchor: 3,51,000) | 47.25% (18.93% ex-anchor) |
| NII (Non-Institutional Investors) | 2,64,000 shares | 14.24% |
| Retail Individual Investors | 6,20,000 shares | 33.44% |
| Anchor Investors | 5,25,000 shares | 28.32% |
| Market Maker | Not disclosed | ~5% |
Note: Strong anchor allocation (28.32%) with ₹6.83 cr commitment. Standard SME IPO allocation pattern.
Objects of the Issue (Fund Utilization)
Fresh Issue Proceeds (₹24.10 crore / ₹2,410 lakhs gross, ₹22.88 cr net) will be used for:
- Marketing and Advertisement Expenses – ₹11.50 crore (50.3% of net proceeds)
- Brand building and visibility enhancement
- Digital marketing campaigns (Google Ads, Meta, influencer partnerships)
- Customer acquisition across Amazon, Flipkart, Myntra, Blinkit
- Performance marketing and retention programs
- Building brand recall in crowded D2C beauty market
- Setting Up New Manufacturing Facility at Mauje-Peth, Amravati – ₹7.80 crore (34.1% of net proceeds)
- Backward integration strategy
- Own manufacturing facility replacing contract manufacturing dependency
- In-house production capabilities for quality control
- Cost reduction through manufacturing economies of scale
- Located in Amravati, Maharashtra
- General Corporate Purposes – Balance amount (~15.6%)
- Working capital, product development, technology infrastructure
Strategic Focus:
- Massive marketing push (50.3%) to compete with established brands
- Backward integration (34.1%) reducing contract manufacturing dependency
- Heavy brand-building approach typical of D2C consumer brands
- No OFS – all proceeds for company growth
Note: This is a 100% fresh issue with no OFS. All proceeds go to the company.
Lead Managers & Registrar
Book Running Lead Manager (BRLM):
- Marwadi Chandarana Intermediaries Brokers Private Limited
- Address: X-change Plaza, Office No. 1201 to 1205, 12th Floor, Building No. 53E, Zone-5, Road 5E, Gift City, Gandhinagar – 382355, Gujarat
- Phone: +91 22 6912 0027
- Website: ib.marwadichandaranagroup.com
Registrar:
- Kfin Technologies Limited
- Address: KFintech, Tower-B, Plot No 31 & 32, Financial District, Nanakramguda, Gachibowli, Hyderabad, Telangana – 500 032
- Phone: 040-6716 2222, 040-7961 1000
- Website: https://ipostatus.kfintech.com/
Promoters & Management
Key Promoter:
- Mr. Ayush Mahesh Verma – Founder & Managing Director (Age 31)
- Sole promoter driving the company
- Founded Ravelcare in November 2018 at age 25
- Appeared on Shark Tank India (as per Instagram: “As seen on Shark Tank India”)
- Bootstrapped the business to profitability
- Leading D2C digital-first strategy
- Pre-IPO holding: Significant majority stake
Company History:
- Founded November 2018 – 7 years old (incorporated as Ravelcare Limited)
- Shark Tank India: Featured on popular reality TV show, gaining brand visibility
- Bootstrapped: Self-funded growth without external investor backing (until IPO)
- Operating Model: Digital-first D2C beauty and personal care brand
- Evolution: From direct website sales to omnichannel presence (marketplaces + quick commerce)
- International Expansion: Exporting to UAE, Australia, Canada, Germany, USA, Saudi Arabia
- Workforce: Small team (1-10 employees per Tracxn as of July 2024)
Company Contact:
- Registered Office: Off-126, Neo Corporate Plaza Cabin B, Ramchandra Lane Extension, Malad, Mumbai – 400064, Maharashtra
- Phone: +91 87792 06822, +91-9321438897
- Website: www.ravelcare.com, www.ravelcare.in
- Social Media: Instagram @ravelcare (90K followers) – Strong social presence
COMPANY OVERVIEW
Establishment & Background:
- Incorporated in November 2018 (7 years old)
- Industry: Digital-First Beauty and Personal Care (BPC) – D2C Brand
- Shark Tank India Featured: Gained significant brand visibility through appearance on popular TV show
- Founder: Ayush Mahesh Verma (31 years old, bootstrapped entrepreneur)
- Headquarters: Mumbai, Maharashtra
- Workforce: Small lean team (1-10 employees per Tracxn)
- Social Media: 90K+ Instagram followers – strong digital presence
Business Model:
- Custom, Made-to-Order Beauty & Personal Care Products
- Unique Selling Proposition: Personalized/customized products based on individual customer hair/skin profiles
- Product Categories:
- Haircare: Custom shampoo, conditioner, hair serum, hair oil, hair mask, scalp treatments
- Skincare: Face wash, face serum, moisturizers, cleaners tailored to skin type
- Bodycare: Body lotions, body wash, body scrubs
- Scalp Care: Specialized scalp treatments and serums
- Product Philosophy:
- Clean Beauty: Free from sulfates, parabens, phthalates, mineral oils, GMOs
- Cruelty-Free: No animal testing
- Customization: Products formulated based on customer quiz answers about hair/skin type, concerns, preferences
- Made-to-Order: 2-3 days formulation time per customer order
- Optional: Vegan, silicone-free, fragrance-free variants available
- Natural Ingredients: Sourced from across the world with quality checks
- Distribution Channels:
- Own Website: www.ravelcare.com, www.ravelcare.in (direct D2C)
- E-commerce Marketplaces: Amazon, Flipkart, Myntra (majority of sales)
- Quick Commerce: Blinkit (instant delivery partnerships)
- Exports: UAE, Australia, Canada, Germany, USA, Saudi Arabia (6 countries)
- Revenue Model:
- Primarily B2C retail sales through online channels
- Premium pricing for customized products
- Subscription/repeat purchase potential (32% repeat rate per sources)
- Export sales adding to revenue diversification
- Manufacturing:
- Current: Contract manufacturing (outsourced production)
- Future (IPO funded): Own manufacturing facility in Mauje-Peth, Amravati for backward integration
- Logistics: In-house warehousing and logistics for smooth delivery
Market Position:
- Positioned as customized/personalized beauty brand in growing Indian D2C space
- Competing in highly crowded and competitive beauty & personal care market
- Niche player among giants like Mamaearth (Honasa Consumer), Nykaa, Plum, MCaffeine, Minimalist
- Shark Tank visibility provided brand boost but competing with well-funded players
- Strong social media presence (90K Instagram) indicating digital-first engagement
Operations:
- Headquarters: Mumbai, Maharashtra (Malad)
- Manufacturing: Currently contract manufacturing; setting up own Amravati facility with IPO proceeds
- Delivery Time: 2-3 days product formulation + 4-5 days shipping = ~7 days total
- Customer Service: Phone (+91-9321438897) and email support
- Technology: Quiz-based customization algorithm, e-commerce platform, digital marketing stack
Company Strengths
- Shark Tank India Featured – Brand Visibility & Credibility:
- Appeared on Shark Tank India reality TV show
- Gained significant brand awareness and credibility boost
- Instagram bio highlights “As seen on Shark Tank India”
- TV exposure valuable for D2C brand building in competitive market
- Differentiator vs unknown competitors
- Potential customer trust from Shark Tank association
- Strong Anchor Support – ₹6.83 Cr Raised (28.32% of Issue):
- Significant institutional backing with ₹6.83 crore anchor investment
- 5,25,000 shares subscribed by anchors (28.32% allocation)
- Validates company fundamentals and growth potential
- Provides stability and confidence for retail investors
- Reduces risk of under-subscription
- Customization USP – Differentiated Product Offering:
- Unique personalized/custom product approach vs mass-market brands
- Quiz-based algorithm creates tailored formulations for individual needs
- Made-to-order model (2-3 days formulation) shows commitment to customization
- Addresses diverse Indian hair/skin types better than generic products
- Higher customer engagement through personalization
- Potential for customer loyalty and repeat purchases (32% repeat rate)
- Clean Beauty Focus – Riding Wellness Trend:
- Clean ingredient positioning: Free from sulfates, parabens, phthalates, mineral oils, GMOs
- Cruelty-free commitment appeals to conscious consumers
- Vegan, silicone-free, fragrance-free options available
- Riding global wellness and clean beauty megatrend
- Younger millennials and Gen-Z increasingly prefer clean/natural products
- Alignment with growing health consciousness in India
- Strong Digital Presence – 90K Instagram Followers:
- 90,000+ Instagram followers indicate strong social media engagement
- Digital-first approach aligned with target millennial/Gen-Z audience
- Influencer marketing and content creation capabilities
- Direct customer engagement and feedback loop
- Social proof and brand advocacy visible on platforms
- Omnichannel Distribution – Website + Marketplaces + Quick Commerce:
- Multi-channel presence: Own website, Amazon, Flipkart, Myntra, Blinkit
- Reduces dependency on single platform
- Reaches customers wherever they shop online
- Quick commerce (Blinkit) enables instant gratification
- Export to 6 countries (UAE, Australia, Canada, Germany, USA, Saudi Arabia) provides international diversification
- Backward Integration Plan – Own Manufacturing Facility:
- IPO proceeds (₹7.8 cr) funding own Amravati manufacturing facility
- Reduces contract manufacturing dependency
- Better quality control with in-house production
- Cost advantages through manufacturing economies
- Margin improvement potential
- Greater control over supply chain and production timelines
- Bootstrapped to Profitability – Capital Efficient Growth:
- Achieved profitability without external investor funding
- FY25: ₹5.25 cr PAT on ₹24.98 cr revenue (21% PAT margin) – healthy for D2C
- Capital discipline and lean operations
- Validates business model sustainability
- Profitable SME rare in D2C consumer space
Key Risks & Challenges
- Stagnant Revenue & Profit Growth – “Static Top & Bottom Lines” Warning:
- Critical Analyst Warning (Dilip Davda): “From FY24 onwards, it posted almost static top and bottom lines“
- FY25 revenue: ₹24.98 cr (+12% vs ₹22.28 cr FY24) – slowing growth
- FY25 PAT: ₹5.25 cr (+4.6% vs ₹5.02 cr FY24) – barely growing profits!
- H1 FY26: ₹14.4 cr revenue, ₹3.2 cr PAT (annualized ~₹28.8 cr revenue, ~₹6.4 cr PAT)
- Growth deceleration concerning for D2C brand meant to scale rapidly
- Analyst verdict: “Issue appears fully priced“
- Questions about future growth trajectory and market acceptance
- “Fully Priced” Valuation – Analyst Warns of Limited Upside:
- Analyst Dilip Davda verdict: “Based on its recent financial data, the issue appears fully priced“
- P/E of 12.38x (pre-issue) reasonable but offers limited margin of safety given stagnant growth
- Small D2C brand with minimal growth commanding moderate premium
- No room for disappointment in execution
- Limited upside potential vs downside risk
- “Tiny Post-IPO Capital” – “Longer Gestation for Migration” Warning:
- Critical Warning: “Tiny paid-up capital post-IPO indicates longer gestation for migration“
- Small post-IPO market cap (~₹86 cr)
- Suggests difficulty in graduating to mainboard
- Limited free float and liquidity on SME platform
- May remain SME listing for extended period
- Institutional investors may avoid due to size
- Exit opportunities constrained
- Low GMP (₹12-16) – Subdued Market Enthusiasm:
- GMP of ₹12-16 (9.2-12.3% premium) – moderate at best
- High of ₹16 on Nov 27, low of ₹12 on Nov 26 – not strong momentum
- Indicates limited grey market speculation
- Expected listing gains 9-12% only – modest vs other IPOs
- Market cautious about growth slowdown and competitive intensity
- Highly Competitive D2C Beauty Market – Fighting Giants:
- Intensely crowded space with well-funded players:
- Listed: Honasa Consumer (Mamaearth, The Derma Co – ₹15,000+ cr market cap), Nykaa (₹40,000+ cr)
- Unicorns: Sugar Cosmetics, Purplle
- Strong Brands: Plum, MCaffeine, Minimalist, Wow Skin Science, mCaffeine, Forest Essentials, Kama Ayurveda
- International: L’Oreal, Unilever, P&G entering D2C
- Low barriers to entry – hundreds of new D2C beauty brands launching
- Customer acquisition costs (CAC) rising due to intense competition
- Price wars and discounting eroding margins
- Differentiation difficult to sustain
- Ravelcare’s small size (₹25 cr revenue) vs Mamaearth (₹2,000+ cr) = David vs Goliath
- Intensely crowded space with well-funded players:
- Heavy Marketing Dependence – 50% of IPO for Ads:
- ₹11.5 cr (50.3% of net proceeds) allocated to marketing and advertisement
- Indicates heavy customer acquisition costs typical of D2C
- Continuous marketing spend needed to stay visible
- Rising digital marketing costs (Google, Meta) compressing margins
- Difficult to achieve profitability without sustained marketing burn
- IPO proceeds may not be sufficient for sustained brand building
- Competitors with deeper pockets can outspend Ravelcare
- Contract Manufacturing Dependency – Quality & Cost Risks:
- Currently 100% reliant on contract manufacturers for production
- No control over manufacturing quality, timelines, costs
- Vulnerable to contract manufacturer pricing power
- Quality issues can damage brand reputation
- Supply chain disruptions impact delivery promises (2-3 day formulation claim)
- New Amravati facility (₹7.8 cr) will take 12-18 months to operationalize
- Until then, contract manufacturing dependency continues
- Platform Dependency – Majority Sales via Amazon/Flipkart/Myntra:
- Majority of sales through third-party marketplaces (Amazon, Flipkart, Myntra)
- Platform commissions (15-25%) eroding margins
- Algorithm changes can impact visibility and sales overnight
- Competing with thousands of brands on same platforms
- Difficult to build direct customer relationships
- Brand loyalty limited when customers discover via marketplace search
- Platform policies and fee structures outside company control
- Single Promoter Risk – Founder Concentration:
- Ayush Mahesh Verma is sole promoter and driving force
- Key man risk if founder exits or health issues arise
- Small team (1-10 employees) = limited management depth
- No co-founders or strong second-line leadership visible
- Succession planning unclear for 7-year-old company
- Investor confidence tied to single individual
- Limited Export Revenue – Minimal International Presence:
- Export to only 6 countries (UAE, Australia, Canada, Germany, USA, Saudi Arabia)
- Export revenue likely <5-10% of total based on marketplace-heavy model
- Limited international brand recognition
- Indian D2C brands struggle to compete globally with established players
- Cross-border logistics and regulatory challenges
- International expansion requires significant investment
- Product Complexity – Made-to-Order Model Scalability Challenge:
- Custom made-to-order model (2-3 days formulation) difficult to scale
- Manufacturing complexity increases with customization
- Inventory management challenging with thousands of SKU combinations
- Higher per-unit costs vs mass production
- Delivery timelines (7+ days) vs instant gratification expectations
- Operational inefficiencies as order volumes grow
- Competing with standard products available for next-day delivery
- Regulatory Risks – Cosmetics & Personal Care Compliance:
- Subject to strict FSSAI, CDSCO, BIS regulations for cosmetics and personal care
- Clean beauty claims require substantiation
- Ingredient sourcing and safety testing requirements
- Product recalls or safety issues = brand damage
- International exports require country-specific certifications
- Compliance costs rising with stricter regulations
CRITICAL CONCERNS: Analyst Dilip Davda explicitly warns: “From FY24 onwards, it posted almost static top and bottom lines” and “Issue appears fully priced.” States “Tiny paid-up capital post-IPO indicates longer gestation for migration.” Revenue +12% (FY24-FY25), PAT +4.6% – growth decelerating. Competing in highly crowded D2C beauty market against giants like Mamaearth (Honasa, ₹15,000+ cr market cap), Nykaa (₹40,000+ cr), Plum, MCaffeine. Heavy marketing dependency (50% IPO for ads), contract manufacturing risk, platform dependency (Amazon/Flipkart/Myntra). Modest GMP (₹12-16, 9-12%). Small post-IPO market cap (~₹86 cr).
Disclaimer: This information is based on publicly available sources including SEBI RHP filings, analyst reports, and company disclosures. Investors should conduct their own research and consult with financial advisors before making investment decisions. Past performance is not indicative of future results. SME investments carry higher risks than mainboard listings.
